Akero Therapeutics, Inc.
Industry: Life Sciences ・ $AKRO on Nasdaq
Insider Sale
+$651,400
-21.24%
Shares
Shares Volume: 20,000 Shares
Average Share Price: $32.57
INSIDER
Yale Catriona
Chief Development Officer (Officer)
reported on Nov 1 2024
traded on Oct 30 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 74,158 |
| PURCHASES/SALES 1Y | 0 / 10 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $291,595.58 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 2 |
| PURCHASES/SALES 1Y | 2 / 39 |
| P/S VALUE RATIO | 0.182 |
| AVERAGE SALE VALUE | $519,354.56 |
| COMPANY PREVIOUS TRADES |